A Phase 4 interventional study of Methylphenidate and Intensive reading instruction in Attention Deficit Hyperactivity Disorder and Reading Disabilities, sponsored by The University of Texas Health Science Center, Houston. Completed at 2 sites in United States. Open to participants aged 7 Years to 12 Years. Per ClinicalTrials.gov, last updated 2017-04-11.
Sponsored by The University of Texas Health Science Center, Houston · Phase 4, Interventional, and Treatment
The objective of this randomized clinical trial is to address unanswered questions about the relative effectiveness of treatments for children with both Attention Deficit Hyperactivity Disorder (ADHD) and significant reading difficulties (RD). The study evaluates attentional and word reading outcomes for students with both conditions when provided with either (a) ADHD treatment alone, (b) RD treatment alone, or (c) the combination of ADHD and RD treatment.
The objective of this randomized clinical trial is to address unanswered questions about the relative effectiveness of treatments for children with both Attention Deficit Hyperactivity Disorder (ADHD) and significant reading difficulties (RD). The study evaluates attentional and word reading outcomes for students with both conditions when provided with either (a) disorder-specific ADHD treatment (carefully managed medication + parent training), (b) disorder-specific RD treatment (intensive, individualized reading instruction), or (c) the combination of ADHD and RD treatment. The study aims to address the relative benefits of providing either disorder-specific ADHD or RD treatment alone and providing the combined treatment. The investigators hypothesize that the combined treatment approach will result in better outcomes in terms of both word reading/decoding and a reduction in ADHD symptoms than either of the disorder-specific treatments alone. Treatment will last for 16 weeks, with assessment prior to and following treatment and some measures collected regularly throughout the intervention periods.
124 studies on the registry are indexed under Dyslexia; 27 are open to participants now.
This study's enrollment of 222 is above the median of 76 across 106 interventional studies indexed under Dyslexia.
Browse Dyslexia studies →The University of Texas Health Science Center, Houston is the lead sponsor of 880 studies on the registry; 209 are open to participants now.
Of its 170 completed or terminated interventional studies of FDA-regulated products, 140 (82%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Specialized phonologically-based reading instruction provided by well-trained tutors either individually (one-on-one) or to groups of two students for 45 minutes, four days per week, for 16 weeks. The instructional approach includes an individualized combination of published programs targeting word reading and decoding; reading fluency; and reading comprehension.
Behavioral: Intensive reading instruction
Carefully-managed medication and behavioral parent training. Medication treatment begins with a four-week titration period, beginning with a trial of methylphenidate. If benefit is insufficient or side effects are intolerable, the physician may initiate a trial of mixed salt amphetamine, followed by either Atomoxetine or Guanfacine. When the optimum medication and dosage is determined the child returns for monthly medication maintenance visits until the end of the 16-week intervention period. Parent training consists of nine group sessions provided by a psychologist addressing ADHD and its treatment, principals of behavior modification, and evidence-supported practices for managing behavior.
Drug: Methylphenidate · Behavioral: Parent Training · Drug: Mixed Salt Amphetamine · Drug: Atomoxetine · Drug: Guanfacine
All interventions described in Reading Instruction and ADHD treatment arms: Phonologically-based reading instruction provided for 45 minutes, four days per week, for 16 weeks. Carefully-managed medication and behavioral parent training. Medication treatment begins with a trial of methylphenidate. If benefit is insufficient or side effects are intolerable, the physician may initiate a trial of mixed salt amphetamine, followed by either Atomoxetine or Guanfacine. When the optimum medication and dosage is determined the child returns for monthly medication maintenance visits until the end of the 16-week intervention period. Parent training consists of nine group sessions on parenting a child with ADHD.
Drug: Methylphenidate · Behavioral: Intensive reading instruction · Behavioral: Parent Training · Drug: Mixed Salt Amphetamine · Drug: Atomoxetine · Drug: Guanfacine
Appropriate dosage to be individually determined; daily for 16 weeks
Also known as: Concerta Extended Release, Ritalin
Individualized phonologically-based instruction delivered 4 days per week for 45 min. per day by a highly trained tutor.
Nine sessions on parenting a child with ADHD
Appropriate dosage to be individually determined; daily for 16 weeks; prescribed only if child does not show a beneficial treatment response to Concerta
Also known as: Adderall Extended Release (XR)
Appropriate dosage to be individually determined; daily for 16 weeks
Also known as: Strattera
Appropriate dosage to be individually determined; daily for 16 weeks
Also known as: Intuniv
Swanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Parent Rating of Inattention
Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV (Diagnostic and Statistical Manual) ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).
Time frame: 16 weeks (end of Active Treatment phase), and follow-up
Swanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Parent Rating of Hyperactivity-impulsivity
Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV (Diagnostic and Statistical Manual) ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).
Time frame: 16 weeks (end of Active Treatment phase), and follow-up
Swanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Teacher Rating of Inattention
Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).
Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up
Swanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Teacher Rating of Hyperactivity-impulsivity
Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).
Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up
Wechsler Individual Achievement Test-III (WIAT-III) Word Reading Subtest
The WIAT-III is an individually-administered test of academic achievement. In the Word Reading subtest students read a list of increasingly difficult words. Scores reported here are standardized scores with a mean of 100 and standard deviation of 15.
Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up
Wechsler Individual Achievement Test-III (WIAT-III) Pseudoword Decoding Subtest
The WIAT-III is an individually-administered test of academic achievement. In the Pseudoword Decoding subtest students read a list of increasingly difficult nonsense words as a test of their ability to use phonics to decode unknown words. Scores reported here are standardized scores with a mean of 100 and standard deviation of 15. Higher scores represent a better outcome.
Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up
Wechsler Individual Achievement Test-III (WIAT-III) Reading Comprehension Subtest
The WIAT-III is an individually-administered test of academic achievement. This subtest involves reading sentences and longer passages and then answering a set of literal and inferential comprehension questions about the text. Scores reported here are standardized scores with a mean of 100 and standard deviation of 15. Higher scores represent a better outcome.
Time frame: Week 16, End of Active Treatment Phase
Dynamic Indicators of Basic Early Literacy Skills Oral Reading Fluency Subtest (DIBELS ORF)
DIBELS ORF measures oral reading fluency in connected text. Students are presented with a passage on their grade level to read orally, and the score is the number of words of the passage read correctly in a one-minute period. Students in this study read two passages at each test administration, and the mean score for the two passages was the dependent variable analyzed. A research synthesis of studies reporting psychometric properties for DIBELS ORF determined that reliability coefficients in these studies exceeded .80 and that the measure demonstrated moderate to high concurrent and predictive validity across studies (Goffreda \& DiPerna, 2010).
Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up
Test of Word Reading Efficiency (TOWRE) - Sight Word Efficiency
The TOWRE Sight Word Efficiency subtest measures fluency of reading words in lists. The raw score is the number of words or nonwords identified correctly in 45 seconds. Standard scores with a mean of 100 and standard deviaion of 15 are reported here. Higher scores represent a better outcome.
Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up
Test of Word Reading Efficiency (TOWRE) - Phonemic Decoding Efficiency
The TOWRE Phonemic Decoding Efficiency measures the student's fluent decoding of nonsense words that follow the spelling rules of the English language. The raw score is the number of nonwords identified correctly in 45 seconds. Standardized scores with a mean of 100 and standard deviaion of 15 are reported here. Higher scores represent a better outcome.
Time frame: Week 16 (End of Active Treatment Phase) and Follow-Up
Test of Silent Reading Fluency and Comprehension (TOSREC)
The TOSREC measures sentence-level comprehension and silent reading fluency. It is a sentence verification task; children are presented with a list of sentences and must tell whether they are true or false. Items are based on common knowledge (e.g., All apples are blue). The raw score is the number of items answered correctly in 3 minutes. Standardized with a mean of 100 and standard deviation of 15 are reported here. Higher scores represent a better outcome.
Time frame: Week 16, End of Active Treatment Phase
| Milestone | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| Started | 78 | 74 | 70 |
| Completed | 73 | 73 | 67 |
| Not completed | 5 | 1 | 3 |
| Withdrew: Withdrawal by subject | 5 | 1 | 3 |
| Milestone | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| Started | 73 | 73 | 67 |
| Completed | 72 | 70 | 60 |
| Not completed | 1 | 3 | 7 |
| Withdrew: Lost to follow-up | 1 | 3 | 7 |
Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV (Diagnostic and Statistical Manual) ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).
| Units on a scale | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| 16-Week Outcomes | 1.1 ± 0.1 | 1.7 ± 0.1 | 1.0 ± 0.1 |
| Follow-up Outcomes | 1.3 ± 0.1 | 1.6 ± 0.1 | 1.0 ± 0.1 |
Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV (Diagnostic and Statistical Manual) ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).
| units on a scale | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| 16-Week Outcomes | 0.8 ± 0.1 | 1.3 ± 0.1 | 0.6 ± 0.1 |
| Follow-up Outcomes | 0.9 ± 0.1 | 1.4 ± 0.1 | 0.7 ± 0.1 |
Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).
| Units on a scale | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| 16-week Outcomes | 1.2 ± 0.1 | 1.7 ± 0.1 | 1.4 ± 0.1 |
| Follow-Up | 1.5 ± 0.1 | 1.9 ± 0.1 | 1.5 ± 0.1 |
Rating Scale of ADHD symptomology completed by parents and teachers. Raters evaluate how well each DSM-IV ADHD symptom describes a child on a four-point Likert scale (0=Not at all, 1=Just a little, 2=Quite a bit, 3=Very much). The measure shows adequate internal consistency (.94) and test-retest reliability (Bussing et al., 2008; Gau et al., 2008).
| Units on a scale | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| 16-Week Outcomes | 0.7 ± 0.1 | 1.1 ± 0.1 | 0.8 ± 0.1 |
| Follow-up | 0.8 ± 0.1 | 1.1 ± 0.1 | 0.8 ± 0.1 |
The WIAT-III is an individually-administered test of academic achievement. In the Word Reading subtest students read a list of increasingly difficult words. Scores reported here are standardized scores with a mean of 100 and standard deviation of 15.
| standardized scores, M=100, SD = 15 | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| 16-Week Outcomes | 76.9 ± 0.7 | 79.0 ± 0.7 | 79.9 ± 0.7 |
| Follow-Up | 77.1 ± 0.8 | 78.1 ± 0.8 | 78.8 ± 0.8 |
The WIAT-III is an individually-administered test of academic achievement. In the Pseudoword Decoding subtest students read a list of increasingly difficult nonsense words as a test of their ability to use phonics to decode unknown words. Scores reported here are standardized scores with a mean of 100 and standard deviation of 15. Higher scores represent a better outcome.
| standardized scores | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| 16-Week Outcomes | 78.3 ± 1.0 | 83.8 ± 1.0 | 83.0 ± 1.1 |
| Follow-Up | 77.1 ± 1.0 | 82.6 ± 1.1 | 81.9 ± 1.2 |
The WIAT-III is an individually-administered test of academic achievement. This subtest involves reading sentences and longer passages and then answering a set of literal and inferential comprehension questions about the text. Scores reported here are standardized scores with a mean of 100 and standard deviation of 15. Higher scores represent a better outcome.
| standardized scores | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| Wechsler Individual Achievement Test-III (WIAT-III) Reading Comprehension Subtest | 88.27 ± 0.9 | 84.70 ± 0.9 | 86.35 ± 1.0 |
DIBELS ORF measures oral reading fluency in connected text. Students are presented with a passage on their grade level to read orally, and the score is the number of words of the passage read correctly in a one-minute period. Students in this study read two passages at each test administration, and the mean score for the two passages was the dependent variable analyzed. A research synthesis of studies reporting psychometric properties for DIBELS ORF determined that reliability coefficients in these studies exceeded .80 and that the measure demonstrated moderate to high concurrent and predictive validity across studies (Goffreda \& DiPerna, 2010).
| words read correctly per minute | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| 16-Week Outcomes | 53.67 ± 30.3 | 50.71 ± 31.94 | 53.83 ± 33.5 |
| Follow-Up | 63.06 ± 31.97 | 57.40 ± 31.06 | 59.05 ± 31.97 |
The TOWRE Sight Word Efficiency subtest measures fluency of reading words in lists. The raw score is the number of words or nonwords identified correctly in 45 seconds. Standard scores with a mean of 100 and standard deviaion of 15 are reported here. Higher scores represent a better outcome.
| standardized scores | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| 16-Week Outcomes | 80.8 ± 0.82 | 82.7 ± 0.82 | 83.5 ± 0.87 |
| Follow-Up | 83.57 ± 0.82 | 85.04 ± 0.84 | 84.15 ± 0.90 |
The TOWRE Phonemic Decoding Efficiency measures the student's fluent decoding of nonsense words that follow the spelling rules of the English language. The raw score is the number of nonwords identified correctly in 45 seconds. Standardized scores with a mean of 100 and standard deviaion of 15 are reported here. Higher scores represent a better outcome.
| standardized scores | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| 16-Week Outcomes | 80.4 ± 0.79 | 83.4 ± 0.79 | 82.9 ± 0.84 |
| Follow-Up | 81.49 ± 0.83 | 84.50 ± 0.86 | 84.32 ± 0.92 |
The TOSREC measures sentence-level comprehension and silent reading fluency. It is a sentence verification task; children are presented with a list of sentences and must tell whether they are true or false. Items are based on common knowledge (e.g., All apples are blue). The raw score is the number of items answered correctly in 3 minutes. Standardized with a mean of 100 and standard deviation of 15 are reported here. Higher scores represent a better outcome.
| standardized scores | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| Test of Silent Reading Fluency and Comprehension (TOSREC) | 17.40 ± 0.7 | 17.70 ± 0.7 | 18.57 ± 0.75 |
Collected over 6 years. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| ADHD Treatment | — | 0/71 (0%) | 3/71 (4.2%) |
| Intensive Reading Instruction | — | 0/74 (0%) | 1/74 (1.4%) |
| Combined ADHD Treatment and Reading Instruction | — | 0/68 (0%) | 5/68 (7.4%) |
| Event | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction |
|---|---|---|---|
| Aggressive behaviorsSocial circumstances | 3/71 | 1/74 | 5/68 |
Baseline characteristics are for our final analysis sample, consisting of all children randomized to each condition except for 1 in the ADHD arm, 1 in the Reading arm, and 4 in the Combined arm, who were excluded because upon ex post-facto review of records, they did not meet either ADHD, RD, or IQ inclusion criteria and had been included in error.
| Age, Categorical(Participants) | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction | Total |
|---|---|---|---|---|
| <=18 years | 77 | 73 | 66 | 216 |
| Between 18 and 65 years | 0 | 0 | 0 | 0 |
| >=65 years | 0 | 0 | 0 | 0 |
| Sex: Female, Male(Participants) | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction | Total |
|---|---|---|---|---|
| Female | 25 | 24 | 35 | 84 |
| Male | 52 | 49 | 31 | 132 |
| Region of Enrollment(participants) | ADHD Treatment | Intensive Reading Instruction | Combined ADHD Treatment and Reading Instruction | Total |
|---|---|---|---|---|
| United States | 77 | 73 | 66 | 216 |
This study is completed, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The University of Texas Health Science Center, Houston